Background: The purpose of this research was to examine and evaluate the ability of complete blood cells, coagulation, and biochemical tests of interleukin-6, 8, and If- in patients with the virus (COVID-19) in Egypt (Third wave), as well as to assess the findings of the Ct scans. Methods: Fifty patients were used (30 females, 20 males, and ten control groups). In patients with the virus (COVID-19) in Egypt (Third wave), we measured total blood cells, coagulation, and biochemical tests of interleukin-6, 8, and If-, as well as the results of the CT scans.

Results: patients with the virus (COVID-19) had significantly higher white blood cell (WBC), neutrophil, and lymphocyte counts, compared to the control group. The COVID19 virus in patients in Egypt also caused a significant increase in coagulation measurements, liver profile and kidney profile function, and biomarkers of inflammation (Third wave). Both interleukin expressions (IL6 and IL-8) were elevated in COVID-19 virus-infected patients with significant inflammatory activity. There was no statistically significant difference between the proportion of male and female COVID-19 patients with interleukins (IL-6, IL-8, and IF-) at their maximum levels.

Conclusions: We recommend that white blood cell (WBC) count, neutrophil count, lymphocyte count, and IL-6, IL-8, IF-y, serum ferritin, and Creactive protein (CRP) as markers for highly potential progression to critical illness in patients virus (COVID-19) in Egypt (Third wave) who are very ill and the virus is positively spreading between families or friends.